Nykode Therapeutics ASA — Director's Dealing 2021

Sep 10, 2021

Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party

Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party

Jan Haudemann-Andersen, member of the board of Vaccibody AS, owns directly or indirectly Datum AS, Datum Invest AS, Datum Opportunity AS, Datum Vekst AS and Datum Finans AS.

The Datum Group has today, September 10, 2021, reallocated its shareholdings in Vaccibody AS:

Datum Invest AS has sold 5 000 000 shares at NOK 79 per share

Datum AS has sold 21 000 000 shares at NOK 79 per share

Datum Vekst AS has sold 2 395 500 shares at NOK 79 per share

Datum Opportunity AS has bought 26 000 000 shares at NOK 79 per share.

Datum Finans AS has bought 2 395 500 shares at NOK 79 per share.

Following the transactions, the companies’ shareholdings are:

Datum Invest AS - no shares

Datum Vekst AS - no shares

Datum AS - 11 634 250 shares

Datum Opportunity – 26 000 000 shares

Datum Finans AS – 2 395 500 shares

Jan Haudemann-Andersen and the Datum Group hold an unchanged number of 40 263 050 shares in Vaccibody AS after the above transactions.

Please see further details in attached document.